Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia

Anoikis, a cell death mechanism triggered upon cell-matrix detachment, is regarded as a physiological suppressor of metastasis that can be regulated by a diverse array of signals. The protein encoded by GDF2 is BMP9 and is a member of the bone morphogenetic protein family and the transforming growth...

Full description

Bibliographic Details
Main Authors: Archana Varadaraj, Pratik Patel, Anne Serrao, Tirthankar Bandyopadhay, Nam Y. Lee, Amir A. Jazaeri, Zhiqing Huang, Susan K. Murphy, Karthikeyan Mythreye
Format: Article
Language:English
Published: Elsevier 2015-11-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558615001402
_version_ 1817969828430872576
author Archana Varadaraj
Pratik Patel
Anne Serrao
Tirthankar Bandyopadhay
Nam Y. Lee
Amir A. Jazaeri
Zhiqing Huang
Susan K. Murphy
Karthikeyan Mythreye
author_facet Archana Varadaraj
Pratik Patel
Anne Serrao
Tirthankar Bandyopadhay
Nam Y. Lee
Amir A. Jazaeri
Zhiqing Huang
Susan K. Murphy
Karthikeyan Mythreye
author_sort Archana Varadaraj
collection DOAJ
description Anoikis, a cell death mechanism triggered upon cell-matrix detachment, is regarded as a physiological suppressor of metastasis that can be regulated by a diverse array of signals. The protein encoded by GDF2 is BMP9 and is a member of the bone morphogenetic protein family and the transforming growth factor (TGF) β superfamily with emerging yet controversial roles in carcinogenesis. In an attempt to identify the function of growth and differentiation factor 2 (GDF2) in epithelial systems, we examined the signaling machinery that is involved and cell fate decisions in response to GDF2 in ovarian and breast epithelia. We find that GDF2 can robustly activate the SMAD1/5 signaling axis by increasing complex formation between the type I receptor serine threonine kinases activin receptor-like kinase (ALK) 3 and ALK6 and the type II receptor serine threonine kinase BMPRII. This activation is independent of cross talk with the SMAD2-transforming growth factor β pathway. By activating SMAD1/5, epithelial cells regulate anchorage-independent growth by increasing anoikis sensitivity that is dependent on GDF2’s ability to sustain the activation of SMAD1/5 via ALK3 and ALK6. Consistent with a role for GDF2 in promoting anoikis susceptibility, the analysis of cell lines and patient data suggests epigenetic silencing of GDF2 in cancer cell lines and increased promoter methylation in patients. These findings collectively indicate an antimetastatic role for GDF2 in ovarian and breast cancer. The work also implicates loss of GDF2 via promoter methylation-mediated downregulation in promotion of carcinogenesis with significant relevance for the use of epigenetic drugs currently in clinical trials.
first_indexed 2024-04-13T20:27:01Z
format Article
id doaj.art-ca70dc14342c4009be0783c537ea963d
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-04-13T20:27:01Z
publishDate 2015-11-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-ca70dc14342c4009be0783c537ea963d2022-12-22T02:31:19ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022015-11-01171182683810.1016/j.neo.2015.11.003Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast EpitheliaArchana Varadaraj0Pratik Patel1Anne Serrao2Tirthankar Bandyopadhay3Nam Y. Lee4Amir A. Jazaeri5Zhiqing Huang6Susan K. Murphy7Karthikeyan Mythreye8Department of Chemistry and Biochemistry, University of South Carolina, Columbia SC 29208Department of Chemistry and Biochemistry, University of South Carolina, Columbia SC 29208Department of Chemistry and Biochemistry, University of South Carolina, Columbia SC 29208Department of Chemistry and Biochemistry, University of South Carolina, Columbia SC 29208Division of Pharmacology, College of Pharmacy, Columbus, OH 43210Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer CenterDepartment of Gynecology and Oncology, Duke University, Durham NC 29210Department of Gynecology and Oncology, Duke University, Durham NC 29210Department of Chemistry and Biochemistry, University of South Carolina, Columbia SC 29208Anoikis, a cell death mechanism triggered upon cell-matrix detachment, is regarded as a physiological suppressor of metastasis that can be regulated by a diverse array of signals. The protein encoded by GDF2 is BMP9 and is a member of the bone morphogenetic protein family and the transforming growth factor (TGF) β superfamily with emerging yet controversial roles in carcinogenesis. In an attempt to identify the function of growth and differentiation factor 2 (GDF2) in epithelial systems, we examined the signaling machinery that is involved and cell fate decisions in response to GDF2 in ovarian and breast epithelia. We find that GDF2 can robustly activate the SMAD1/5 signaling axis by increasing complex formation between the type I receptor serine threonine kinases activin receptor-like kinase (ALK) 3 and ALK6 and the type II receptor serine threonine kinase BMPRII. This activation is independent of cross talk with the SMAD2-transforming growth factor β pathway. By activating SMAD1/5, epithelial cells regulate anchorage-independent growth by increasing anoikis sensitivity that is dependent on GDF2’s ability to sustain the activation of SMAD1/5 via ALK3 and ALK6. Consistent with a role for GDF2 in promoting anoikis susceptibility, the analysis of cell lines and patient data suggests epigenetic silencing of GDF2 in cancer cell lines and increased promoter methylation in patients. These findings collectively indicate an antimetastatic role for GDF2 in ovarian and breast cancer. The work also implicates loss of GDF2 via promoter methylation-mediated downregulation in promotion of carcinogenesis with significant relevance for the use of epigenetic drugs currently in clinical trials.http://www.sciencedirect.com/science/article/pii/S1476558615001402
spellingShingle Archana Varadaraj
Pratik Patel
Anne Serrao
Tirthankar Bandyopadhay
Nam Y. Lee
Amir A. Jazaeri
Zhiqing Huang
Susan K. Murphy
Karthikeyan Mythreye
Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia
Neoplasia: An International Journal for Oncology Research
title Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia
title_full Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia
title_fullStr Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia
title_full_unstemmed Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia
title_short Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia
title_sort epigenetic regulation of gdf2 suppresses anoikis in ovarian and breast epithelia
url http://www.sciencedirect.com/science/article/pii/S1476558615001402
work_keys_str_mv AT archanavaradaraj epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia
AT pratikpatel epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia
AT anneserrao epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia
AT tirthankarbandyopadhay epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia
AT namylee epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia
AT amirajazaeri epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia
AT zhiqinghuang epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia
AT susankmurphy epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia
AT karthikeyanmythreye epigeneticregulationofgdf2suppressesanoikisinovarianandbreastepithelia